1-(5-deoxy-beta-D-hexofuranosyl)cytosine manufacturers
|
| | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine Basic information |
| Product Name: | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine | | Synonyms: | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine;2(1H)-Pyrimidinone, 4-amino-1-(5-deoxy-β-D-ribo-hexofuranosyl)-;4-Amino-1-(5-deoxy-β-D-ribo-hexofuranosyl)-2(1H)-pyrimidinone;5'-homocytidine;Uridine, 2′,3′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI, ACI) | | CAS: | 55085-34-2 | | MF: | C10H15N3O5 | | MW: | 257.25 | | EINECS: | | | Product Categories: | | | Mol File: | 55085-34-2.mol |  |
| | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine Chemical Properties |
| Boiling point | 542.8±60.0 °C(Predicted) | | density | 1.77±0.1 g/cm3(Predicted) | | pka | 13.55±0.70(Predicted) |
| | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine Usage And Synthesis |
| Uses | 5'- Homocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 1-(5-deoxy-beta-D-hexofuranosyl)cytosine Preparation Products And Raw materials |
|